Climb Bio (CLYM) Current Leases (2022 - 2026)
Climb Bio (CLYM) reported Current Leases of $263000.0 for Q1 2026, up 69.68% on a YoY basis from $155000.0 in Q1 2025, and up 2.73% quarter-over-quarter from $256000.0 in Q4 2025.
Climb Bio (CLYM) Current Leases (2022 - 2026) Analysis & Trends
Climb Bio has reported Current Leases for 5 years, with the latest figure at $263000.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 69.68% year-over-year to $263000.0; the trailing twelve-month figure through Mar 2026 stood at $263000.0 (up 69.68% YoY), and the FY2025 full-year result was $256000.0, up 63.06% from the prior year.
- Current Leases for Q1 2026 stood at $263000.0, up from $256000.0 in the prior quarter.
- The five-year high for Current Leases was $485000.0 in Q2 2023, with the low at $58000.0 in Q3 2024.
- Historically, Current Leases has averaged $288117.6 across 5 years, with a median of $263000.0 in 2026.
- Annual changes were most pronounced in 2024 — Current Leases sank 85.54% — and 2025, when it soared 293.1%.
- Climb Bio's Current Leases stood at $300000.0 in 2022, then advanced by 11.33% to $334000.0 in 2023, then plunged by 52.99% to $157000.0 in 2024, then jumped by 63.06% to $256000.0 in 2025, then rose by 2.73% to $263000.0 in 2026.
- The last three Current Leases figures came in at $263000.0 (Q1 2026), $256000.0 (Q4 2025), and $228000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Climb Bio | 740.73 Mn | 740.73 Mn | - | 263,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 263,000.00 |
| Dec 31, 2025 | 256,000.00 |
| Sep 30, 2025 | 228,000.00 |
| Jun 30, 2025 | 222,000.00 |
| Mar 31, 2025 | 155,000.00 |
| Dec 31, 2024 | 157,000.00 |
| Sep 30, 2024 | 58,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 225,000.00 |
| Dec 31, 2023 | 334,000.00 |
| Sep 30, 2023 | 401,000.00 |
| Jun 30, 2023 | 485,000.00 |
| Mar 31, 2023 | 464,000.00 |
| Dec 31, 2022 | 300,000.00 |
| Sep 30, 2022 | 352,000.00 |
| Jun 30, 2022 | 439,000.00 |
| Mar 31, 2022 | 459,000.00 |